Financhill
Sell
18

KHC Quote, Financials, Valuation and Earnings

Last price:
$24.79
Seasonality move :
4.99%
Day range:
$24.29 - $24.93
52-week range:
$21.99 - $33.35
Dividend yield:
6.45%
P/E ratio:
13.01x
P/S ratio:
1.18x
P/B ratio:
0.70x
Volume:
13.9M
Avg. volume:
17.2M
1-year change:
-15.21%
Market cap:
$29.4B
Revenue:
$24.9B
EPS (TTM):
-$4.94
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $26B $26.5B $26.6B $25.8B $24.9B
Revenue Growth (YoY) -0.54% 1.69% 0.59% -2.98% -3.5%
 
Cost of Revenues $17.5B $18.4B $17.6B $16.9B $16.6B
Gross Profit $8.6B $8.1B $9.1B $9B $8.4B
Gross Profit Margin 32.97% 30.48% 34.03% 34.78% 33.58%
 
R&D Expenses $140M $127M $147M $150M $167M
Selling, General & Admin $5.2B $4.5B $4.4B $7.3B --
Other Inc / (Exp) -$1.4B -$687M -$729M -$3.7B --
Operating Expenses $3.5B $3.5B $3.7B $3.6B $3.7B
Operating Income $5.1B $4.5B $5.4B $5.4B $4.7B
 
Net Interest Expenses $2.1B $928M $920M $932M $974M
EBT. Incl. Unusual Items $1.7B $3B $3.6B $856M -$5.4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $684M $598M $787M -$1.9B $403M
Net Income to Company $1B $2.4B $2.8B $2.7B -$5.8B
 
Minority Interest in Earnings $12M $5M -$9M $2M -$2M
Net Income to Common Excl Extra Items $1B $2.4B $2.8B $2.7B -$5.8B
 
Basic EPS (Cont. Ops) $0.83 $1.93 $2.33 $2.27 -$4.93
Diluted EPS (Cont. Ops) $0.82 $1.91 $2.31 $2.26 -$4.93
Weighted Average Basic Share $1.2B $1.2B $1.2B $1.2B $1.2B
Weighted Average Diluted Share $1.2B $1.2B $1.2B $1.2B $1.2B
 
EBITDA $6B $5.5B $6.3B $6.3B $5.7B
EBIT $5.1B $4.5B $5.4B $5.4B $4.7B
 
Revenue (Reported) $26B $26.5B $26.6B $25.8B $24.9B
Operating Income (Reported) $5.1B $4.5B $5.4B $5.4B $4.7B
Operating Income (Adjusted) $5.1B $4.5B $5.4B $5.4B $4.7B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $6.7B $7.4B $6.9B $6.6B $6.4B
Revenue Growth (YoY) -3.32% 10.02% -7.06% -4.14% -3.38%
 
Cost of Revenues $4.7B $5B $4.5B $4.3B $4.3B
Gross Profit $2B $2.4B $2.4B $2.3B $2.1B
Gross Profit Margin 30.5% 32.25% 34.71% 34.43% 32.78%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.2B $1.1B $1B $2.3B --
Other Inc / (Exp) -$1.2B $33M -$133M -$1.4B --
Operating Expenses $868M $1.1B $989M $863M $980M
Operating Income $1.2B $1.3B $1.4B $1.4B $1.1B
 
Net Interest Expenses $623M $218M $231M $233M $244M
EBT. Incl. Unusual Items -$520M $1.1B $950M -$238M $897M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$265M $164M $193M -$2.4B $249M
Net Income to Company -$255M $887M $757M $2.1B $648M
 
Minority Interest in Earnings $2M -$3M -- $1M -$3M
Net Income to Common Excl Extra Items -$255M $887M $757M $2.1B $648M
 
Basic EPS (Cont. Ops) -$0.21 $0.73 $0.62 $1.77 $0.55
Diluted EPS (Cont. Ops) -$0.21 $0.72 $0.61 $1.77 $0.55
Weighted Average Basic Share $1.2B $1.2B $1.2B $1.2B $1.2B
Weighted Average Diluted Share $1.2B $1.2B $1.2B $1.2B $1.2B
 
EBITDA $1.4B $1.5B $1.6B $1.6B $1.4B
EBIT $1.2B $1.3B $1.4B $1.4B $1.1B
 
Revenue (Reported) $6.7B $7.4B $6.9B $6.6B $6.4B
Operating Income (Reported) $1.2B $1.3B $1.4B $1.4B $1.1B
Operating Income (Adjusted) $1.2B $1.3B $1.4B $1.4B $1.1B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $26B $26.5B $26.6B $25.8B $24.9B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $17.5B $18.4B $17.6B $16.8B $16.6B
Gross Profit $8.5B $8.1B $9.1B $9B $8.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $5.1B $3.6B $4.4B $7.3B $12B
Other Inc / (Exp) -$1.4B -$687M -$729M -$3.7B --
Operating Expenses $3.5B $3.5B $3.7B $3.6B $3.7B
Operating Income $5B $4.5B $5.4B $5.4B $4.7B
 
Net Interest Expenses $2.1B $922M $918M $923M $981M
EBT. Incl. Unusual Items $1.7B $3B $3.6B $856M -$5.4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $684M $598M $787M -$1.9B $403M
Net Income to Company $1B $2.4B $2.8B $2.7B -$5.8B
 
Minority Interest in Earnings $12M $5M -$9M $2M -$2M
Net Income to Common Excl Extra Items $1B $2.4B $2.8B $2.7B -$5.8B
 
Basic EPS (Cont. Ops) $0.83 $1.93 $2.33 $2.28 -$4.94
Diluted EPS (Cont. Ops) $0.82 $1.92 $2.31 $2.26 -$4.94
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $5.9B $5.5B $6.3B $6.4B $5.6B
EBIT $5B $4.5B $5.4B $5.4B $4.7B
 
Revenue (Reported) $26B $26.5B $26.6B $25.8B $24.9B
Operating Income (Reported) $5B $4.5B $5.4B $5.4B $4.7B
Operating Income (Adjusted) $5B $4.5B $5.4B $5.4B $4.7B
Period Ending 2022-12-31 2023-12-31 2024-12-31 2025-12-31 2026-12-31
Revenue $26.5B $26.6B $25.8B $24.9B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $18.4B $17.6B $16.8B $16.6B --
Gross Profit $8.1B $9.1B $9B $8.3B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3.6B $4.4B $7.3B $12B --
Other Inc / (Exp) -$687M -$729M -$3.7B -$9.2B --
Operating Expenses $3.5B $3.7B $3.6B $3.7B --
Operating Income $4.5B $5.4B $5.4B $4.7B --
 
Net Interest Expenses $922M $918M $923M $981M --
EBT. Incl. Unusual Items $3B $3.6B $856M -$5.4B --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $598M $787M -$1.9B $403M --
Net Income to Company $2.4B $2.8B $2.7B -$5.8B --
 
Minority Interest in Earnings $5M -$9M $2M -$2M --
Net Income to Common Excl Extra Items $2.4B $2.8B $2.7B -$5.8B --
 
Basic EPS (Cont. Ops) $1.93 $2.33 $2.28 -$4.94 --
Diluted EPS (Cont. Ops) $1.92 $2.31 $2.26 -$4.94 --
Weighted Average Basic Share $4.9B $4.9B $4.8B $4.7B --
Weighted Average Diluted Share $4.9B $4.9B $4.9B $4.8B --
 
EBITDA $5.5B $6.3B $6.4B $5.6B --
EBIT $4.5B $5.4B $5.4B $4.7B --
 
Revenue (Reported) $26.5B $26.6B $25.8B $24.9B --
Operating Income (Reported) $4.5B $5.4B $5.4B $4.7B --
Operating Income (Adjusted) $4.5B $5.4B $5.4B $4.7B --
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Cash and Equivalents $3.4B $1B $1.4B $1.4B $3.8B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2B $2.1B $2.1B $2.1B $2.3B
Inventory $2.7B $3.7B $3.6B $3.4B $3.2B
Prepaid Expenses $136M $240M $234M $215M $291M
Other Current Assets $716M $842M $569M $583M --
Total Current Assets $9B $7.9B $7.9B $7.7B $10.1B
 
Property Plant And Equipment $7.4B $7.4B $7.7B $7.7B $7.8B
Long-Term Investments $182M $108M $112M $196M $173M
Goodwill $31.3B $30.8B $30.5B $28.7B --
Other Intangibles $43.5B $42.6B $42.4B $40.1B --
Other Long-Term Assets $2.8B $2.4B $2.4B $4.7B --
Total Assets $93.4B $90.5B $90.3B $88.3B $81.8B
 
Accounts Payable $4.8B $4.8B $4.6B $4.2B $4.3B
Accrued Expenses $1.1B $1B $991M $960M --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $1.9B $2.3B $1.8B $1.5B --
Total Current Liabilities $9.1B $9B $8B $7.3B $8.8B
 
Long-Term Debt $21.5B $19.8B $19.9B $19.7B $19.7B
Capital Leases -- -- -- -- --
Total Liabilities $43.9B $41.6B $40.6B $39B $40B
 
Common Stock $12M $12M $12M $12M $12M
Other Common Equity Adj -$1.8B -$2.8B -$2.6B -$2.9B --
Common Equity $49.3B $48.7B $49.5B $49.2B $41.7B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $154M $192M $196M $140M $125M
Total Equity $49.5B $48.9B $49.7B $49.3B $41.8B
 
Total Liabilities and Equity $93.4B $90.5B $90.3B $88.3B $81.8B
Cash and Short Terms $3.4B $1B $1.4B $1.4B $3.8B
Total Debt $22.3B $20.6B $20.5B $20.3B $21.6B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Cash and Equivalents $3.4B $1B $1.4B $1.4B $3.8B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2B $2.1B $2.1B $2.1B $2.3B
Inventory $2.7B $3.7B $3.6B $3.4B $3.2B
Prepaid Expenses $136M $240M $234M $215M $291M
Other Current Assets $716M $842M $569M $583M --
Total Current Assets $9B $7.9B $7.9B $7.7B $10.1B
 
Property Plant And Equipment $7.4B $7.4B $7.7B $7.7B $7.8B
Long-Term Investments $182M $108M $112M $196M $173M
Goodwill $31.3B $30.8B $30.5B $28.7B --
Other Intangibles $43.5B $42.6B $42.4B $40.1B --
Other Long-Term Assets $2.8B $2.4B $2.4B $4.7B --
Total Assets $93.4B $90.5B $90.3B $88.3B $81.8B
 
Accounts Payable $4.8B $4.8B $4.6B $4.2B $4.3B
Accrued Expenses $1.1B $1B $991M $960M --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $1.9B $2.3B $1.8B $1.5B --
Total Current Liabilities $9.1B $9B $8B $7.3B $8.8B
 
Long-Term Debt $21.5B $19.8B $19.9B $19.7B $19.7B
Capital Leases -- -- -- -- --
Total Liabilities $43.9B $41.6B $40.6B $39B $40B
 
Common Stock $12M $12M $12M $12M $12M
Other Common Equity Adj -$1.8B -$2.8B -$2.6B -$2.9B --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $154M $192M $196M $140M $125M
Total Equity $49.5B $48.9B $49.7B $49.3B $41.8B
 
Total Liabilities and Equity $93.4B $90.5B $90.3B $88.3B $81.8B
Cash and Short Terms $3.4B $1B $1.4B $1.4B $3.8B
Total Debt $22.3B $20.6B $20.5B $20.3B $21.6B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $1B $2.4B $2.8B $2.7B -$5.8B
Depreciation & Amoritzation $910M $933M $961M $948M $968M
Stock-Based Compensation $197M $148M $141M $109M $95M
Change in Accounts Receivable $87M -$228M $18M -$139M -$55M
Change in Inventories -$144M -$1.1B -$106M -$6M $133M
Cash From Operations $5.4B $2.5B $4B $4.2B $4.5B
 
Capital Expenditures $905M $916M $1B $1.2B $801M
Cash Acquisitions $74M $481M -- -- --
Cash From Investing $4B -$1.1B -$916M -$1B -$1.8B
 
Dividends Paid (Ex Special Dividend) $2B $2B $2B $1.9B $1.9B
Special Dividend Paid
Long-Term Debt Issued -- $238M $807M $594M --
Long-Term Debt Repaid -$7.1B -$1.7B -$998M -$618M --
Repurchase of Common Stock -- -- $455M $988M $436M
Other Financing Activities $12M -$19M -$67M -$65M --
Cash From Financing -$9.3B -$3.7B -$2.7B -$3B -$1.3B
 
Beginning Cash (CF) $3.4B $1B $1.4B $1.4B $2.8B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $28M -$2.4B $363M $82M $1.5B
Ending Cash (CF) $3.4B -$1.4B $1.7B $1.4B $4.3B
 
Levered Free Cash Flow $4.5B $1.6B $3B $3B $3.7B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders -$255M $887M $757M $2.1B $648M
Depreciation & Amoritzation $233M $248M $251M $234M $251M
Stock-Based Compensation $42M $41M $31M $26M $25M
Change in Accounts Receivable -$5M -$20M $34M -$56M -$2M
Change in Inventories $120M -$94M $171M $386M $338M
Cash From Operations $2.9B $952M $1.4B $1.4B $1.4B
 
Capital Expenditures $250M $284M $234M $247M $205M
Cash Acquisitions $74M -$20M -- $5M --
Cash From Investing $1.3B -$53M -$178M -$174M -$223M
 
Dividends Paid (Ex Special Dividend) $490M $490M $491M $479M $474M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $10M $150M -- --
Long-Term Debt Repaid -$2.4B -$291M -$175M -$11M --
Repurchase of Common Stock -- -- $455M $450M $1M
Other Financing Activities $154M $148M -$41M -$22M --
Cash From Financing -$3B -$903M -$862M -$962M -$488M
 
Beginning Cash (CF) $3.4B $1B $1.4B $1.4B $2.8B
Foreign Exchange Rate Adjustment -$27M $47M $34M -$54M $28M
Additions / Reductions $1.2B $43M $350M $198M $693M
Ending Cash (CF) $4.6B $1.1B $1.8B $1.5B $3.5B
 
Levered Free Cash Flow $2.7B $668M $1.1B $1.1B $1.2B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $1B $2.4B $2.8B $2.7B -$5.8B
Depreciation & Amoritzation $910M $933M $961M $948M $968M
Stock-Based Compensation $197M $148M $141M $109M $95M
Change in Accounts Receivable $87M -$228M $18M -$139M -$55M
Change in Inventories -$144M -$1.1B -$106M -$6M $133M
Cash From Operations $5.4B $2.5B $4B $4.2B $4.5B
 
Capital Expenditures $905M $916M $1B $1.2B $801M
Cash Acquisitions $74M $481M -- -- --
Cash From Investing $4B -$1.1B -$916M -$1B -$1.8B
 
Dividends Paid (Ex Special Dividend) $2B $2B $2B $1.9B $1.9B
Special Dividend Paid
Long-Term Debt Issued -- -- $807M $594M --
Long-Term Debt Repaid -$7.1B -$1.7B -$998M -$618M --
Repurchase of Common Stock -- -- $455M $988M $436M
Other Financing Activities $12M -$19M -$67M -$65M --
Cash From Financing -$9.3B -$3.7B -$2.7B -$3B -$1.3B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $28M -$2.4B $363M $82M $1.5B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $4.5B $1.6B $3B $3B $3.7B
Period Ending 2022-12-31 2023-12-31 2024-12-31 2025-12-31 2026-12-31
Net Income to Stockholders $2.4B $2.8B $2.7B -$5.8B --
Depreciation & Amoritzation $933M $961M $948M $968M --
Stock-Based Compensation $148M $141M $109M $95M --
Change in Accounts Receivable -$228M $18M -$139M -$55M --
Change in Inventories -$1.1B -$106M -$6M $133M --
Cash From Operations $2.5B $4B $4.2B $4.5B --
 
Capital Expenditures $916M $1B $1.2B $801M --
Cash Acquisitions $481M -- -- -- --
Cash From Investing -$1.1B -$916M -$1B -$1.8B --
 
Dividends Paid (Ex Special Dividend) $2B $2B $1.9B $1.9B --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $238M $807M $594M $1.6B --
Long-Term Debt Repaid -$1.7B -$998M -$618M -$676M --
Repurchase of Common Stock -- $455M $988M $436M --
Other Financing Activities -$19M -$67M -$65M $19M --
Cash From Financing -$3.7B -$2.7B -$3B -$1.3B --
 
Beginning Cash (CF) $6.5B $4.2B $5.2B $8.7B --
Foreign Exchange Rate Adjustment -$69M -$19M -$71M $80M --
Additions / Reductions -$2.4B $363M $82M $1.5B --
Ending Cash (CF) $4.1B $4.6B $5.2B $10.2B --
 
Levered Free Cash Flow $1.6B $3B $3B $3.7B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 34x

Sell
44
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Buy
77
CPS alert for Feb 14

Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.

Buy
58
TPH alert for Feb 14

Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.

Sell
20
IRON alert for Feb 14

Disc Medicine, Inc. [IRON] is down 21.88% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock